Skip to main content

Table 2 Demographic characteristics of RB patients with different hope scores (N = 317)

From: Hope level and associated factors among parents of retinoblastoma patients during COVID-19 pandemic: a cross-sectional study

Characteristics

N (%)

hope score \( \left(\overline{\boldsymbol{x}}\pm \boldsymbol{s}\right) \)

F-value /t-value

P-value

Age, years

  ≤ 2

60(18.93)

35.82 ± 4.15

0.337*

0.799

  > 2,≤3

90(28.39)

35.09 ± 3.57

  

  > 3,≤5

117(35.91)

35.30 ± 4.85

  

  > 5

50(15.78)

35.44 ± 5.10

  

Sex

 Male

167(52.68)

35.06 ± 4.94

−1.294#

0.197C

 Female

150(47.32)

35.69 ± 3.74

  

Time since diagnosis, months

  ≤ 6

44(13.88)

36.02 ± 4.72

0.930*

0.447

  > 6,≤12

65(20.50)

35.09 ± 4.06

  

  > 12,≤24

102(32.18)

35.65 ± 4.29

  

  > 24,≤36

75(23.66)

35.28 ± 4.40

  

  > 36

31(9.78)

34.23 ± 5.14

  

Ocular disease

 Monoculus

225(70.98)

35.52 ± 4.27

−2.303#

0.022C

 Binoculus

92(29.02)

34.97 ± 4.76

  

Tumor stage at diagnosisa

 A/B/C

15(4.73)

35.80 ± 3.12

0.580*

0.629

 D

132(41.64)

35.43 ± 4.38

  

 E

156(49.21)

35.14 ± 4.55

  

 Extraocular

14(4.42)

36.64 ± 4.60

  

Treatment types b

  ≤ 4

131(41.32)

34.90 ± 4.61

2.972*

0.053

 4–6

158(49.84)

35.94 ± 4.36

  

  > 6

28(8.84)

34.25 ± 3.42

  

Times of hospitalizations

  ≤ 6

110(34.70)

35.36 ± 4.26

1.650*

0.194

 6–10

94(29.65)

35.97 ± 4.31

  

  > 10

113(35.65)

34.85 ± 4.64

  

Disease state

 Under treatment

108(34.07)

34.72 ± 4.09

1.711*

0.182

 Under reexamine

206(64.98)

35.69 ± 4.59

  

 Had cured

3(0.95)

35.60 ± 7.58

  
  1. Note. N Number; * = F value; # = t value; Bold face p < 0.05.
  2. aintraocular retinoblastoma was classified by the International Classification of Retinoblastoma as group A; group B; group C; group D; and group E.
  3. bthe sum of the treatment types methods (such as intravenous chemotherapy, intra-arterial chemotherapy, examination under anesthesia, enucleation, intracameral chemotherapy, intravitreal chemotherapy, cataract surgery, onsolidation therapies, pars plana vitrectomy, anti-neovasculariztion therapy, and cradiation-based therapies) that have been used so far.
  4. CP-values calculated from Independent sample t-test; all other P-values were obtained by using the One-way ANOVA test.